Researchers pinpoint how PARP inhibitors combat BRCA1 and BRCA2 tumor cells
Argentina starts distributing local Sputnik vaccine
12 August 2021Weight fluctuations may predict poor outcomes in adults with kidney disease
12 August 2021Researchers pinpoint how PARP inhibitors combat BRCA1 and BRCA2 tumor cells
A team of Massachusetts General Hospital (MGH) researchers has discovered how an important class of anti-cancer drugs called PARP inhibitors works, a finding that could help improve treatment and prolong survival for patients with breast cancer and other malignancies.
